Steinerbio

SteinerBio is revolutionizing regenerative medicine in dental bone grafting. Located in the Las Vegas Valley, SteinerBio is a pioneering female-owned biotech company specializing in patented osteogenic bone regenerative materials. Our mission is to provide clinicians with innovative, science-backed solutions that go beyond traditional grafting methods, ensuring patients receive the best outcomes in bone regeneration and implantology. Unlike traditional bone grafts that simply fill voids, SteinerBio’s proprietary material stimulates the patient’s natural bone growth process. Our products are fully resorbed, leaving behind the patient’s own healthy, vital bone—restoring function and health without residual foreign material. Our founder, Dr. Greg Steiner, DDS, MS, brings decades of expertise in dental implantology and bone biology. Our President and CEO, Roslynn Steiner, is a pioneering startup business leader in the biotech space, leading SteinerBio as a female-owned and female-led company in an industry where women remain underrepresented in leadership roles. Backed by rigorous scientific research and FDA clearance, our products address critical gaps in dental bone grafting practices and patient safety. Mission At SteinerBio, we aim to advance the science of bone regeneration, challenge outdated practices in dentistry, and empower clinicians and patients with safe, effective solutions for natural bone regeneration. What Makes Our Products Different? Traditional grafts often leave behind non-resorbing materials that can result in sclerotic bone incapable of remodeling. SteinerBio products stimulate the patient’s own osteoblasts, promoting healthy bone regeneration without any residual graft material. We are committed to educating both clinicians and patients about the critical importance of bone biology. Contact us to explore our products or discuss how SteinerBio can help improve patient outcomes in your practice. contactus@steinerbio.com